Redox activation of metal-based prodrugs as a strategy for drug delivery
Top Cited Papers
Open Access
- 31 August 2012
- journal article
- review article
- Published by Elsevier BV in Advanced Drug Delivery Reviews
- Vol. 64 (11), 993-1004
- https://doi.org/10.1016/j.addr.2012.01.007
Abstract
No abstract availableKeywords
This publication has 112 references indexed in Scilit:
- Targeted delivery of a cisplatin prodrug for safer and more effective prostate cancer therapy in vivoProceedings of the National Academy of Sciences of the United States of America, 2011
- Mitaplatin, a potent fusion of cisplatin and the orphan drug dichloroacetateProceedings of the National Academy of Sciences of the United States of America, 2009
- Polymer−Cisplatin Conjugate Nanoparticles for Acid-Responsive Drug DeliveryACS Nano, 2009
- Polyvalent Oligonucleotide Gold Nanoparticle Conjugates as Delivery Vehicles for Platinum(IV) WarheadsJournal of the American Chemical Society, 2009
- Postsynthetic Modifications of Iron-Carboxylate Nanoscale Metal−Organic Frameworks for Imaging and Drug DeliveryJournal of the American Chemical Society, 2009
- Targeted delivery of cisplatin to prostate cancer cells by aptamer functionalized Pt(IV) prodrug-PLGA–PEG nanoparticlesProceedings of the National Academy of Sciences of the United States of America, 2008
- Targeted Single-Wall Carbon Nanotube-Mediated Pt(IV) Prodrug Delivery Using Folate as a Homing DeviceJournal of the American Chemical Society, 2008
- New trends for metal complexes with anticancer activityCurrent Opinion in Chemical Biology, 2008
- Conjugated Platinum(IV)−Peptide Complexes for Targeting Angiogenic Tumor VasculatureBioconjugate Chemistry, 2007
- Soluble Single-Walled Carbon Nanotubes as Longboat Delivery Systems for Platinum(IV) Anticancer Drug DesignJournal of the American Chemical Society, 2007